help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaffe, J. S.
Right arrow Articles by Schulman, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaffe, J. S.
Right arrow Articles by Schulman, E. S.

Am. J. Respir. Cell Mol. Biol., Vol 13, No. 6, Dec 1995, 665-675.

Human lung mast cell IL-5 gene and protein expression: temporal analysis of upregulation following IgE-mediated activation

JS Jaffe, MC Glaum, DG Raible, TJ Post, E Dimitry, D Govindarao, Y Wang and ES Schulman
Division of Allergy and Immunology, Hahnemann University, Philadelphia, Pennsylvania 19102, USA.

The late-phase of allergic asthma is characterized by infiltration of the airway with eosinophils within 6 h of mast cell activation. Pro- eosinophilic/pro-allergic (TH2) cytokines, originally described as T- lymphocyte products, have recently been ascribed to mast cells as well. To date, however, it is unknown if TH2 cytokine gene expression by the human mast cells is subject to receptor-mediated regulation analogous to that of T-cells, and if messenger RNA (mRNA) expression results in protein secretion occurring in a temporal context consistent with the late-phase response. We examined interleukin-4 (IL-4), IL-5, and IL-6 mRNA expression induced by anti-IgE activation of human lung explants as assessed using reverse transcription/polymerase chain reaction (RT- PCR). Anti-IgE stimulation resulted in rapid and sustained upregulation of IL-5 message, but did not have analogous effects on IL-4 or IL-6. Using quantitative-competitive PCR, we demonstrated that 100 ng of total cellular RNA from human lung contained 1 fg of IL-5 mRNA; this increased to 100 fg 4 h after anti-IgE activation. The source of the anti-IgE-enhanced IL-5 mRNA is likely the mast cell itself, as anti-CD3 activation of lung led to a dissimilar array of cytokine expression. In addition, human lung mast cells purified to near homogeneity expressed IL-5 mRNA after activation, as shown by both RT-PCR and in situ hybridization. In both lung fragments and purified human lung mast cells, the modulation of IL-5 mRNA expression preceded the secretion of IL-5 protein, detected as early as 4 h after activation. Neither isolated purified mast cells nor purified peripheral blood T cells could be induced to secrete detectable amounts of IL-5 protein when activated only with antibodies against IgE or CD3-T cell receptor complex, respectively. However, mast cells (n = 4) and T cells (n = 6) cultured at comparable concentrations (4 x 10(6)/ml) activated through their respective antigen receptors in the presence of phorbol ester yielded comparable IL-5 production (253 +/- 126 pg/ml versus 183 +/- 75 pg/ml, mean +/- SE). We conclude that mast cells are analogous to T cells in the requirement of co-stimuli for the production of IL-5 protein. Moreover, the rapid kinetics of IgE-mediated IL-5 transcription and protein elaboration are consistent with a primary role for mast cell activation directly leading to late-phase airway eosinophilia.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
C. M. Fitzsimmons, S. Joseph, F. M. Jones, C. M. Reimert, K. F. Hoffmann, F. Kazibwe, G. Kimani, J. K. Mwatha, J. H. Ouma, E. M. Tukahebwa, et al.
Chemotherapy for Schistosomiasis in Ugandan Fishermen: Treatment Can Cause a Rapid Increase in Interleukin-5 Levels in Plasma but Decreased Levels of Eosinophilia and Worm-Specific Immunoglobulin E
Infect. Immun., July 1, 2004; 72(7): 4023 - 4030.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. S. SCHULMAN
Development of a Monoclonal Anti-Immunoglobulin E Antibody (Omalizumab) for the Treatment of Allergic Respiratory Disorders
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): S6 - 11.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Nakajima, K. Matsumoto, H. Suto, K. Tanaka, M. Ebisawa, H. Tomita, K. Yuki, T. Katsunuma, A. Akasawa, R. Hashida, et al.
Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells
Blood, August 15, 2001; 98(4): 1127 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Salvi, A. Semper, A. Blomberg, J. Holloway, Z. Jaffar, A. Papi, L. Teran, R. Polosa, F. Kelly, T. Sandström, et al.
Interleukin-5 Production by Human Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 984 - 991.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. T. Wise, T. J. Baginski, and J. L. Mobley
An Adoptive Transfer Model of Allergic Lung Inflammation in Mice Is Mediated by CD4+CD62LlowCD25+ T Cells
J. Immunol., May 1, 1999; 162(9): 5592 - 5600.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
E. S. Schulman, M. C. Glaum, T. Post, Y. Wang, D. G. Raible, J. Mohanty, J. H. Butterfield, and A. Pelleg
ATP Modulates Anti-IgE-Induced Release of Histamine from Human Lung Mast Cells
Am. J. Respir. Cell Mol. Biol., March 1, 1999; 20(3): 530 - 537.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1995 American Thoracic Society.
  2009/2010 ATS Fellows Career Development Awards